Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 2812.64 | 359 / 359 | 100% | 78.66 | 286 / 286 |
esophagus | 100% | 3487.59 | 1444 / 1445 | 100% | 75.50 | 183 / 183 |
prostate | 100% | 3173.71 | 245 / 245 | 100% | 81.32 | 501 / 502 |
breast | 100% | 4044.42 | 459 / 459 | 100% | 127.16 | 1115 / 1118 |
brain | 100% | 6404.20 | 2642 / 2642 | 100% | 176.80 | 703 / 705 |
intestine | 100% | 3927.15 | 966 / 966 | 100% | 88.78 | 525 / 527 |
uterus | 100% | 4997.00 | 170 / 170 | 99% | 127.01 | 456 / 459 |
thymus | 100% | 4418.06 | 652 / 653 | 99% | 103.10 | 600 / 605 |
lung | 99% | 2890.79 | 573 / 578 | 100% | 86.62 | 1152 / 1155 |
bladder | 100% | 4224.33 | 21 / 21 | 99% | 105.30 | 498 / 504 |
adrenal gland | 100% | 4243.29 | 258 / 258 | 99% | 343.43 | 227 / 230 |
kidney | 100% | 2845.73 | 89 / 89 | 98% | 75.73 | 885 / 901 |
ovary | 100% | 6167.78 | 180 / 180 | 97% | 50.82 | 418 / 430 |
pancreas | 98% | 1744.58 | 320 / 328 | 99% | 90.13 | 177 / 178 |
skin | 100% | 3537.90 | 1807 / 1809 | 97% | 96.91 | 458 / 472 |
liver | 88% | 1254.43 | 200 / 226 | 96% | 55.49 | 390 / 406 |
adipose | 100% | 4118.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4121.77 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 87.68 | 29 / 29 |
muscle | 100% | 9196.36 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2896.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 101.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 48.37 | 1 / 1 |
heart | 95% | 4027.18 | 818 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 45.44 | 69 / 80 |
peripheral blood | 37% | 1018.35 | 347 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_1990166 | Biological process | protein localization to site of double-strand break |
GO_1903241 | Biological process | U2-type prespliceosome assembly |
GO_0005686 | Cellular component | U2 snRNP |
GO_0005654 | Cellular component | nucleoplasm |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005684 | Cellular component | U2-type spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0160004 | Molecular function | poly-ADP-D-ribose modification-dependent protein binding |
GO_0140463 | Molecular function | chromatin-protein adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HTATSF1 |
Protein name | HIV-1 Tat specific factor 1 17S U2 SnRNP complex component HTATSF1 (HIV Tat-specific factor 1) (Tat-SF1) |
Synonyms | |
Description | FUNCTION: Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs . The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing . Within the 17S U2 SnRNP complex, HTATSF1 is required to stabilize the branchpoint-interacting stem loop . HTATSF1 is displaced from the 17S U2 SnRNP complex before the stable addition of the 17S U2 SnRNP complex to the spliceosome, destabilizing the branchpoint-interacting stem loop and allowing to probe intron branch site sequences . Also acts as a regulator of transcriptional elongation, possibly by mediating the reciprocal stimulatory effect of splicing on transcriptional elongation . Involved in double-strand break (DSB) repair via homologous recombination in S-phase by promoting the recruitment of TOPBP1 to DNA damage sites . Mechanistically, HTATSF1 is (1) recruited to DNA damage sites in S-phase via interaction with poly-ADP-ribosylated RPA1 and (2) phosphorylated by CK2, promoting recruitment of TOPBP1, thereby facilitating RAD51 nucleofilaments formation and RPA displacement, followed by homologous recombination . .; FUNCTION: (Microbial infection) In case of infection by HIV-1, it is up-regulated by the HIV-1 proteins NEF and gp120, acts as a cofactor required for the Tat-enhanced transcription of the virus. . |
Accessions | ENST00000535601.5 Q5H918 ENST00000218364.5 ENST00000448450.5 O43719 ENST00000425695.5 Q5H919 |